James E Sharman
Overview
Explore the profile of James E Sharman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
257
Citations
3416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Picone D, Schultz M, Armstrong M, Black J, Dwyer N, Roberts-Thomson P, et al.
Hypertens Res
. 2025 Mar;
PMID: 40033142
Differences between automated cuff oscillometric blood pressure (BP) and invasive measurements are well described, but the causes are not fully understood. Automated BP devices record cuff oscillometric mean arterial pressure...
2.
3.
Sharman J, Takeuchi F, Protogerou A, Weber T, Wassertheurer S, Marwick T
J Hypertens
. 2025 Feb;
43(4):698-704.
PMID: 39927979
Background: Central SBP purports to aid hypertension management. This concept is founded on cross-sectional studies; however, findings are mixed and few report longitudinal relationships between changes in blood pressure (BP)...
4.
Evaluation of health-related quality of life changes in an Australian rapid access chest pain clinic
Black J, Sharman J, Chen G, Palmer A, de Graaff B, Nelson M, et al.
BMC Health Serv Res
. 2025 Jan;
25(1):8.
PMID: 39748242
Objective: To evaluate the impact of absolute cardiovascular risk counselling on quality-of-life indices within a chest pain clinic. Data Sources And Study Setting: Primary data was collected at the Royal...
5.
Deconinck O, Sharman J, Bishop W, Lees C, Dare L, Hardikar A, et al.
Heart Lung Circ
. 2024 Nov;
34(1):77-83.
PMID: 39613585
Background: Familial hypercholesterolemia (FH) is an under-recognised but common genetic condition resulting in elevated levels of low-density lipoprotein cholesterol (LDL-C) and a high risk of premature coronary disease. The prevalence...
6.
Meng Y, Sharman J, Iiskala F, Wu F, Juonala M, Pahkala K, et al.
JAMA Pediatr
. 2024 Nov;
179(1):34-45.
PMID: 39495520
Importance: Despite its relevance for pediatric blood pressure (BP) screening, the long-term predictive utility and natural progression of pediatric BP classification remain understudied. Objective: To evaluate BP tracking from childhood...
7.
Black J, Eaves S, Chapman N, Campbell J, Bui T, Cho K, et al.
Heart
. 2024 Oct;
110(24):1395-1400.
PMID: 39384383
Background: Rapid Access Chest Pain Clinics (RACPC) are widely used for the outpatient assessment of chest pain, but there appears to be limited high-quality evidence justifying this model of care....
8.
Bonner C, Sharman J, McKinn S, Cornell S, Nelson M, Doust J, et al.
Aust J Gen Pract
. 2024 Sep;
53(9):675-681.
PMID: 39226607
Background And Objectives: Previous research identified numerous barriers to general practitioner (GP) use of cardiovascular disease (CVD) risk guidelines, and it is unclear whether these issues have been resolved. This...
9.
Chapman N, Jayasinghe S, Moore M, Picone D, Schultz M, Jose M, et al.
Hypertens Res
. 2024 Aug;
47(10):2855-2863.
PMID: 39152256
Clinic blood pressure (BP) is recommended for absolute cardiovascular disease (CVD) risk assessment. However, in 'real-world' settings, clinic BP measurement is unstandardised and less reliable compared to more rigorous methods...
10.
Chapman N, Breslin M, Zhou Z, Sharman J, Nelson M, McManus R
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124648
Cardiovascular disease (CVD) primary prevention guidelines classify people at high risk and recommended for pharmacological treatment based on clinical criteria and absolute CVD risk estimation. Despite relying on similar evidence,...